Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Peer Review channel feed
Design Therapeutics hints at ‘strategic realignment,’ replaces CEO; Karyopharm co-founder leads ATP's Nereid
Last year
Century Therapeutics nabs Bristol Myers alum as CEO; Enhertu star Daiichi Sankyo makes changes in Europe
Last year
CNS biotech Rapport snags a CFO veteran from Karuna; Bristol Myers’ new CEO to chair the board next year
Last year
Flagship's Montai Health hires first CMO; Finance leader to retire at J&J partner Xencor
Last year
Co-founded by David Baker, Vilya rings in a permanent CEO; Allogene names Eric Schmidt's CFO successor
Last year
Poseida promotes cell therapy president to CEO; After IPO, Neumora appoints R&D chief
Last year
Dave Lennon's CEO adventure goes from preclinical to commercial; GSK vet embarks on new Odyssey with Gary Glick
Last year
People
Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editas
Last year
Mark Velleca takes over at Black Diamond; Verve Therapeutics separates CMO, CSO posts
Last year
Phil Vickers talks new role as head of Longwood’s Solu after Faze shutdown; Regeneron CFO to retire in February
Last year
Glyscend taps CEO to lead oral obesity, type 2 diabetes candidate; Ex-Travecta chief bounces back after company shutdown
Last year
David Khougazian joins Flagship to build ‘partnerships with different flavors’; Former Novo Nordisk exec to lead Evaxion
Last year
Bayer enlists Jürgen Eckhardt to leap into an additional role; Mirati tops list of multiple CFO exits
Last year
Flagship recruits ex-Magenta CEO to lead Ampersand; Biogen's head of research leaves for Alltrna
Last year
Voyager taps new business chief amid 'significant interest' from partners; Oncopeptides faces another CEO, CFO reset
Last year
Brent Saunders keeps rolling out the changes at Bausch + Lomb; Incyte CSO to exit next month
Last year
Cyrus Mozayeni follows ADC 'beacon' to Pheon CEO role; BeiGene loses business chief to Teva
Last year
Exclusive: After CureVac, Igor Splawski moves to RTW stealth startup; Lyndra's Jessica Ballinger adds CEO title amid commercial prep
Last year
Deborah Birx enters new phase as biotech CEO; Verastem chief announces his retirement
Last year
Lynn Seely brings ex-Myovant colleague to Lyell's C-suite; Nkarta, Zai Lab name new CFOs
Last year
Ex-Galapagos medical chief heads to uniQure; Martin Mackay lines up Rallybio successor
Last year
Sebastian Guth sharpens his focus at Bayer; As CD47 struggles persist, I-Mab appoints CEO
Last year
Ex-Metacrine chief Preston Klassen recharges at microRNA biotech; Allogene begins search for a CFO
Last year
Chemomab changes CEOs, suspends mid-stage trial; Ex-FDA vaccine official lends more help to Mesoblast
Last year
First page
Previous page
1
2
3
4
5
6
7
Next page
Last page
